CStone Pharmaceuticals (HK:2616)
:2616
Earnings Data
Report Date
Aug 20, 2026TBA (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
-0.22Last Year’s EPS
-0.24Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
HK:2616 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
HK:2616 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Mar 26, 2026 | HK$6.89 | HK$6.90 | +0.15% |
Aug 14, 2025 | HK$7.42 | HK$7.45 | +0.40% |
Mar 27, 2025 | HK$3.43 | HK$3.50 | +2.04% |
Aug 23, 2024 | HK$1.31 | HK$1.28 | -2.29% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does CStone Pharmaceuticals (HK:2616) report earnings?
CStone Pharmaceuticals (HK:2616) is schdueled to report earning on Aug 20, 2026, TBA (Confirmed).
What is CStone Pharmaceuticals (HK:2616) earnings time?
CStone Pharmaceuticals (HK:2616) earnings time is at Aug 20, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of CStone Pharmaceuticals stock?
The P/E ratio of CStone Pharmaceuticals is N/A.
What is HK:2616 EPS forecast?
HK:2616 EPS forecast for the fiscal quarter 2026 (Q2) is -0.22.